AI-PROGNOSIS
@aiprognosis.bsky.social
41 followers 94 following 61 posts
AI-PROGNOSIS - a Horizon Europe-funded project developing Artificial intelligence-based solution for Parkinson’s disease risk assessment and prognosis. AI-PROGNOSIS receives funding from the European Union under Grant Agreement No. 101080581.
Posts Media Videos Starter Packs
@aiprognosis.bsky.social joins #IEEEHealthCom 2025 in Abu Dhabi. Project team members will join Panel I: Digital Bridges for Better Health – AI Innovation from Europe to MENA.
🔗 Detailed programme: healthcom2025.ieee-healthcom.org/program/detailed-program

#DigitalHealth #HealthTech
@aiprognosis.bsky.social will join #IEEEHealthCom 2025 in Abu Dhabi! The team will present two papers on how #AI and #wearables can support monitoring and management of #ParkinsonsDisease.
🗓️ 21 Oct 2025
🔗 healthcom2025.ieee-healthcom.org/program/detailed-program

#DigitalHealth #HorizonEurope
💡 Tracking symptoms is important in #Parkinsons care – but tracking alone is not enough.
In @aiprognosis.bsky.social, participants stressed that data matters only when it leads to actionable insights that support daily life and clinical care.
🔗 bit.ly/3J5qlfx

#DigitalHealth
Help improve #Parkinsons care. Share your opinion in the
@aiprognosis.bsky.social survey on using AI to support Parkinson’s care.
👥 Adults 18+, people with Parkinson’s, caregivers & healthcare professionals welcome.
🌍 English, French, German, Spanish

Take part: ai-prognosis.eu/survey
Life with Parkinson’s is more than managing symptoms. It’s about selfcare, support, and partnership.
New article now on the @aiprognosis.bsky.social Learning Hub: Living with Parkinson’s Disease

👉 Read here: www.ai-prognosis.eu/articles

#Parkinsons #LivingWithParkinsons
@aiprognosis.bsky.social partner NeuroTransData attended ECTRIMS 2025 – the leading MS research congress.

A great occasion to network and raise visibility for the AI-PROGNOSIS project in the wider neurodegeneration and digital health community.

#ECTRIMS2025 #ResearchCollaboration
📚 Getting a #Parkinsons diagnosis is often a long journey. Early, subtle signs may appear years before motor symptoms, but without a single test, doctors must rely on clinical evaluation.

Read the full article on the @aiprognosis.bsky.social Learning Hub:
👉 www.ai-prognosis.eu/learning-hub...
💡 AI can support better #Parkinson’s care – but what do patients & healthcare professionals think?
In @aiprognosis.bsky.social, they see opportunities in earlier diagnosis & personalised care, but raise concerns about trust, privacy & oversight.

👉 Read more: www.ai-prognosis.eu/news/trust-a...
💡 AI in healthcare isn’t just about algorithms – it’s about people. In @aiprognosis.bsky.social, people with Parkinson’s, caregivers & healthcare professionals help co-create digital tools built on trust, inclusivity & real needs.
👉 www.ai-prognosis.eu/news/shaping...

#Parkinsons #AI #CoCreation
💡What does it take to launch a clinical study across multiple sites? @aiprognosis.bsky.social set up consistent recruitment protocols, secured regulatory approvals, and tackled early operational challenges during the launch of its first clinical study (dBM-DEV).
🔗 zenodo.org/records/1554...
📌 Ioannis Gerasimou (Aristotle University of Thessaloniki (AUTH)) presented the @aiprognosis.bsky.social paper “Wrist Accelerometry-based Digital Assessment of Slowness of Movement in Parkinson’s Disease: a Multi-Cohort Analysis” at #EMBC2025.

#ParkinsonsDisease #DigitalBiomarkers
@aiprognosis.bsky.social is part of a thematic cluster with @iprolepsis.bsky.social and REBECCA project, exploring how AI and real-world data can improve personalised healthcare.

#AIinHealthcare #DigitalHealth #RealWorldData #Parkinsons #HorizonEurope #HaDEA #PersonalisedCare
💡 Only 5% of healthcare data is used in clinical research, yet 80% of outcomes are shaped by daily life.(Deloitte, 2023)
@iprolepsis.bsky.social, @aiprognosis.bsky.social & REBECCA projects are exploring how AI and real-world data can personalise healthcare.
Read more: iprolepsis.eu/news/iprolep...
@aiprognosis.bsky.social was presented at the 2025 International Symposium of Gait and Posture Research (ISPGR) in Maastricht (June 30-July 2).
Harris Sotirakis (AUTH) represented the project during the session: “Measures, measures, measures… and what about the outcomes?”
#ISPGR2025
“I want to learn as much as possible about #Parkinson’s. Most important, I want to know how I can affect my disease.”
– Janet shares her story via @aiprognosis.bsky.social

Read the full story:
👉 www.ai-prognosis.eu/patient-voic...

#parkinsons #parkinsonsdisease #patientvoices
How can digital biomarkers support #Parkinson’s disease monitoring? @aiprognosis.bsky.social introduces a first version of dBMs to track motor & non-motor symptoms using wearables, smartphone data & digital tests –towards predictive models for PD risk & progression.
🔗 zenodo.org/records/1554...
📢 Deadline Extended – Call for IEEE HealthCom Workshop Papers!
Workshop: "AI-enabled Digital Health Tools for Non-Communicable Diseases: From Concepts to Impact"

@aiprognosis.bsky.social @iprolepsis.bsky.social
📚 𝐓𝐡𝐞 𝐀𝐈-𝐏𝐌𝐏 𝐬𝐭𝐮𝐝𝐲 𝐢𝐬 𝐮𝐧𝐝𝐞𝐫𝐰𝐚𝐲! Ethics approval received in 🇫🇷 (CHU de Toulouse). Protocol submitted in 🇩🇪 (Technical University of Dresden); 🇪🇸 (Foundation for Initiatives in Neuroscience) submission coming soon.
AI tools to support #Parkinsons care → www.ai-prognosis.eu/clinical-stu...
#parkinsons
“𝐈 𝐡𝐚𝐝 𝐛𝐞𝐞𝐧 𝐞𝐱𝐜𝐞𝐩𝐭𝐢𝐨𝐧𝐚𝐥𝐥𝐲 𝐡𝐞𝐚𝐥𝐭𝐡𝐲, 𝐬𝐨 𝐭𝐡𝐞 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐢𝐬 𝐜𝐚𝐦𝐞 𝐚𝐬 𝐚 𝐬𝐡𝐨𝐜𝐤”– Ahlén Henrik, Sweden
Diagnosed with #Parkinson’s at 67, he now contributes to @aiprognosis.bsky.social to support better tools and awareness.
🔗 Read his story: www.ai-prognosis.eu/patient-voic...
#parkinsons
patient voice Ahlen | AI-PROGNOSIS
www.ai-prognosis.eu